Abstract
There is no consensus on the monitoring of liver function tests after Roux-en-Y gastric bypass (RYGB). Since the main objective of such monitoring would be to diagnose early those who will eventually develop liver failure after RYGB, we performed a systematic review on this topic. An extensive search of literature revealed only 10 such cases in 6 published articles. It would hence appear that liver failure is a rare problem after RYGB. Routine lifelong monitoring of liver function tests is therefore unnecessary for otherwise asymptomatic individuals. Such monitoring should hence be reserved for high-risk groups, such as patients with liver cirrhosis, those undergoing extended limb/distal RYGB, patients with new illnesses, those abusing alcohol, those on hepatotoxic drugs and those presenting with a surgical complication.
Similar content being viewed by others
Abbreviations
- NAFLD:
-
Non-alcoholic fatty liver disease
- NASH:
-
Non-alcoholic steato-hepatitis
- LFTs:
-
Liver function tests
- RYGB:
-
Roux-en-Y gastric bypass
- BOMSS:
-
British Obesity and Metabolic Surgery Society
- ASMBS:
-
American Society for Metabolic & Bariatric Surgery
- PRISMA:
-
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
- NA:
-
Not available
- NOS:
-
Not otherwise specified
References
Subichin M, Clanton J, Makuszewski M, Bohon A, Zografakis JG, Dan A. Liver disease in the morbidly obese: a review of 1000 consecutive patients undergoing weight loss surgery. Surg Obes Relat Dis. 2015;11(1):137–41.
Reha JL, Lee S, Hofmann LJ. Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience. Am Surg. 2014;80(6):595–9.
Losekann A, Weston AC, Carli LA, Espindola MB, Pioner SR, Coral GP. Nonalcoholic fatty liver disease in severe obese patients, subjected to bariatric surgery. Arq Gastroenterol. 2013;50(4):285–9.
Praveenraj P, Gomes RM, Kumar S, Karthikeyan P, Shankar A, Parthasarathi R, Senthilnathan P, Rajapandian S, Palanivelu C. Prevalence and predictors of non-alcoholic fatty liver disease in morbidly obese south Indian patients undergoing bariatric surgery. Obes Surg. 2015.
Seki Y, Kakizaki S, Horiguchi N, Hashizume H, Tojima H, Yamazaki Y, Sato K, Kusano M, Yamada M, Kasama K. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery. J Gastroenterol 2015.
Brolin RE, Bradley LJ, Taliwal RV. Unsuspected cirrhosis discovered during elective obesity operations. Arch Surg. 1998;133(1):84–8.
Shimizu H, Phuong V, Maia M, Kroh M, Chand B, Schauer PR, Brethauer SA. Bariatric surgery in patients with liver cirrhosis. Surg Obes Relat Dis. 2013;9(1):1–6.
Dallal RM, Mattar SG, Lord JL, Watson AR, Cottam DR, Eid GM, Hamad G, Rabinovitz M, Schauer PR. Results of laparoscopic gastric bypass in patients with cirrhosis. Obes Surg. 2004;14(1):47–53.
Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric Surgery Worldwide 2013. Obes Surg. 2015;25(10):1822–32.
Caiazzo R, Lassailly G, Leteurtre E, Baud G, Verkindt H, Raverdy V, Buob D, Pigeyre M, Mathurin P, Pattou F. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg. 2014;260(5):893–8 .discussion 898-9
Clark JM, Alkhuraishi AR, Solga SF, Alli P, Diehl AM, Magnuson TH. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease. Obes Res. 2005;13(7):1180–6.
de Almeida SR, Rocha PR, Sanches MD, Leite VH, da Silva RA, Diniz MT, Diniz Mde F, Rocha AL. Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity. Obes Surg. 2006;16(3):270–8.
Cazzo E, Jimenez LS, Pareja JC, Chaim EA. Effect of Roux-en-Y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study. Obes Surg. 2015;25(6):982–5.
Billeter AT, Senft J, Gotthardt D, et al. Combined non-alcoholic fatty liver disease and type 2 diabetes mellitus: sleeve gastrectomy or gastric bypass?—a controlled matched pair study of 34 patients. Obes Surg. 2015.
Diniz Mde F, Moura LD, Kelles SM, Diniz MT. Long-term mortality of patients submitted to Roux-en-Y gastric bypass in public health system: high prevalence of alcoholic cirrhosis and suicides. Arq Bras Cir Dig. 2013;26(Suppl 1):53–6.
Requarth JA, Burchard KW, Colacchio TA, Stukel TA, Mott LA, Greenberg ER, Weismann RE. Long-term morbidity following jejunoileal bypass. The continuing potential need for surgical reversal. Arch Surg. 1995;130(3):318–25.
Berzigotti A, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Morillas R, Escorsell A, Garcia-Pagan JC, Patch D, Matloff DS, Groszmann RJ, Portal Hypertension Collaborative Group. Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology. 2011;54(2):555–61.
Odstrcil EA, Martinez JG, Santa Ana CA, Xue B, Schneider RE, Steffer KJ, Porter JL, Asplin J, Kuhn JA, Fordtran JS. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr. 2010;92(4):704–13.
O’Kane M, Pinkney J, Aasheim E, Barth J, Batterham R, Welbourn R. BOMSS GP Guidance. Adopted by BOMSS Council 2014. http://www.bomss.org.uk/wp-content/uploads/2014/09/GP_Guidance-Final-version-1Oct141.pdf. Accessed 12 Apr 2016.
O’Kane M, Pinkney J, Aasheim E, Barth J, Batterham R, Welbourn R., BOMSS Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery. Adopted by BOMSS Council September 2014. http://www.bomss.org.uk/wp-content/uploads/2014/09/BOMSS-guidelines-Final-version1Oct14.pdf. Accessed 12 Apr 2016.
Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, Heinberg LJ, Kushner R, Adams TD, Shikora S, Dixon JB, Brethauer S, American Association of Clinical Endocrinologists; Obesity Society; American Society for Metabolic & Bariatric Surgery. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring). 2013;21(Suppl 1):S1–27. doi:10.1002/oby.20461.
Mayo Ossorio MA, Pacheco Garcia JM, Pérez Gomar D, Bazán Hinojo Mdel C, Vilchez Lopez FJ, Aguilar Diosdad M, Fernández Serrano JL. Long-term fulminant hepatic failure in patients undergoing gastric bypass for morbid obesity. Nutr Hosp 2015; 32(1): 430–434.
Sgambato D, Cotticelli G, de Sio I, Funaro A, Del Prete A, de Sio C, Romano L, Federico A, Gravina A, Miranda A, Loguercio C, Romano M. Liver failure in an obese middle-aged woman after biliointestinal bypass. World J Clin Cases. 2013;1(1):52–5.
D'Albuquerque LA, Gonzalez AM, Wahle RC, de Oliveira Souza E, Mancero JM, de Oliveira e Silva A. Liver transplantation for subacute hepatocellular failure due to massive steatohepatitis after bariatric surgery. Liver Transpl. 2008;14(6):881–5.
Murr MM, Balsiger BM, Kennedy FP, Mai JL, Sarr MG. Malabsorptive procedures for severe obesity: comparison of pancreaticobiliary bypass and very very long limb Roux-en-Y gastric bypass. J Gastrointest Surg. 1999;3(6):607–12.
Willaert W, Henckens T, Van De Putte D, Van Renterghem K, Ceelen W, Pattyn P, Van Nieuwenhove Y. Life-threatening side effects of malabsorptive procedures in obese patients necessitating conversion surgery: a review of 17 cases. Acta Chir Belg. 2012;112(4):268–74.
van Dongen JL, Michielsen PP, Van den Eynden GG, Pelckmans PA, Francque SM. Rapidly evolving liver decompensation with some remarkable features 14 years after biliopancreatic derivation: a case report and literature review. Acta Gastroenterol Belg 2010 Jan. 73(1): 46–51.
Rodríguez Silva C, Fernández Aguilar JL, Sánchez Pérez B, Suárez Muñoz MÁ, Santoyo Santoyo J. Acute liver failure secondary to bariatric surgery: an indication for liver transplantation. Cir Esp 2016 94(2):113–114. doi:10.1016/j.ciresp.2015.02.013. Epub 2015.
Al-Nowaylati AR, Al-Haddad BJ, Dorman RB, Alsaied OA, Lake JR, Chinnakotla S, Slusarek BM, Sampson BK, Ikramuddin S, Buchwald H, Leslie DB. Gastric bypass after liver transplantation. Liver Transpl. 2013;19(12):1324–9.
Marszałek R, Ziemiański P, Łągiewska B, Pacholczyk M, Domienik-Karłowicz J, Trzebicki J, Wierzbicki Z, Jankowski K, Kosieradzki M, Wasiak D, Jonas M, Pruszczyk P, Durlik M, Lisik W, Chmura A. The first Polish liver transplantation after Roux-en-Y gastric bypass surgery for morbid obesity: a case report and literature review. Ann Transplant. 2015;20:112–5.
Kartiko S, Ortiz J, Hashemi N, Miick R, Dallal R. Acute liver failure complicating jejunojejunal intussusception presentation in a gastric bypass patient. World J Hepatol 2012 Nov. 4(11): 311–313.
SJ C, Vitello JM, Guzman G, Testa G, Benedetti E, Layden TJ. Hepatic decompensation after gastric bypass surgery for severe obesity. Dig Dis Sci. 2004;49(10):1563–8.
Goossens N, Hoshida Y, WM S, Jung M, Morel P, Nakagawa S, Zhang B, JL F, Spahr L, SL F, S, Rubbia-Brandt L, Giostra E. Nonalcoholic steatohepatitis is associated with increased mortality in obese patients undergoing bariatric surgery. Clin Gastroenterol Hepatol. 2015. doi:10.1016/j.cgh.2015.10.010.
Jan A, Narwaria M, Mahawar KK. A systematic review of bariatric surgery in patients with liver cirrhosis. Obes Surg. 2015;25(8):1518–26.
Kruschitz R, Luger M, Kienbacher C, Trauner M, Klammer C, Schindler K, Langer FB, Prager G, Krebs M, Ludvik B. The effect of Roux-en-Y vs. omega-loop gastric bypass on liver, metabolic parameters, and weight loss. Obes Surg. 2016.
Mahawar KK, Parmar C, Graham Y, Abouleid A, Carr WR, Jennings N, Schroeder N, Small PK. Routine liver biopsy during bariatric surgery: an analysis of evidence base. Obes Surg. 2016;26(1):177–81.
Welbourn R, Small P, Finlay, I, Sarela A, Somers S, Mahawar K. Second National Bariatric Surgery Report. http://www.bomss.org.uk/wp-content/uploads/2014/04/Extract_from_the_NBSR_2014_Report.pdf. Accessed 12 Apr 2016
Lohlun JC, Guirguis A, Wise L. Elevated liver enzymes following open Roux-en-Y gastric bypass for morbid obesity - does timing of liver retraction affect the rise in the levels of transaminases? Obes Surg. 2004;14(4):505–8.
Nguyen NT, Braley S, Fleming NW, Lambourne L, Rivers R, Wolfe BM. Comparison of postoperative hepatic function after laparoscopic versus open gastric bypass. Am J Surg. 2003;186(1):40–4.
Nguyen NT, Masoomi H, Laugenour K, Sanaiha Y, Reavis KM, Mills SD, Stamos MJ. Predictive factors of mortality in bariatric surgery: data from the Nationwide Inpatient Sample. Surg Obes Relat Dis 2008; 4(2): 159–164; discussion 164–165.
Dillemans B, Sakran N, Van Cauwenberge S, Sablon T, Defoort B, Van Dessel E, Akin F, Moreels N, Lambert S, Mulier J, Date R, Vandelanotte M, Feryn T, Proot L. Standardization of the fully stapled laparoscopic Roux-en-Y gastric bypass for obesity reduces early immediate postoperative morbidity and mortality: a single center study on 2606 patients. Obes Surg. 2009;19(10):1355–64.
Agaba EA, Shamseddeen H, Gentles CV, Sasthakonar V, Gellman L, Gadaleta D. Laparoscopic vs open gastric bypass in the management of morbid obesity: a 7-year retrospective study of 1,364 patients from a single center. Obes Surg. 2008;18(11):1359–63.
Mahawar KK, Kumar P, Parmar C, et al. Small bowel limb lengths and Roux-en-Y gastric bypass: a systematic review. Obes Surg. 2016;26(3):660–71.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Statement of Human and Animal Rights
Not applicable
Statement of Informed Consent
Not applicable
Rights and permissions
About this article
Cite this article
Mahawar, K.K., Parmar, C., Graham, Y. et al. Monitoring of Liver Function Tests after Roux-en-Y Gastric Bypass: An Examination of Evidence Base. OBES SURG 26, 2516–2522 (2016). https://doi.org/10.1007/s11695-016-2280-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-016-2280-3